36
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Stroke Riskometer™ App: Validation of a data collection tool and stroke risk predictor

      research-article
      1 , * , 1 , 2 , 2 , 2 , 3 , 3 , 3 ,   4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 8 , 25 , 26 , 27 , 7 , 9 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , Stroke Riskometer™ Collaboration Writing Group
      International Journal of Stroke
      BlackWell Publishing Ltd
      prevention, stroke prediction, Stroke Riskometer™ App, validation

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The greatest potential to reduce the burden of stroke is by primary prevention of first-ever stroke, which constitutes three quarters of all stroke. In addition to population-wide prevention strategies (the ‘mass’ approach), the ‘high risk’ approach aims to identify individuals at risk of stroke and to modify their risk factors, and risk, accordingly. Current methods of assessing and modifying stroke risk are difficult to access and implement by the general population, amongst whom most future strokes will arise. To help reduce the burden of stroke on individuals and the population a new app, the Stroke Riskometer™, has been developed. We aim to explore the validity of the app for predicting the risk of stroke compared with current best methods.

          Methods

          752 stroke outcomes from a sample of 9501 individuals across three countries (New Zealand, Russia and the Netherlands) were utilized to investigate the performance of a novel stroke risk prediction tool algorithm (Stroke Riskometer™) compared with two established stroke risk score prediction algorithms (Framingham Stroke Risk Score [FSRS] and QStroke). We calculated the receiver operating characteristics (ROC) curves and area under the ROC curve (AUROC) with 95% confidence intervals, Harrels C-statistic and D-statistics for measure of discrimination, R 2 statistics to indicate level of variability accounted for by each prediction algorithm, the Hosmer-Lemeshow statistic for calibration, and the sensitivity and specificity of each algorithm.

          Results

          The Stroke Riskometer™ performed well against the FSRS five-year AUROC for both males (FSRS = 75·0% (95% CI 72·3%–77·6%), Stroke Riskometer™ = 74·0(95% CI 71·3%–76·7%) and females [FSRS = 70·3% (95% CI 67·9%–72·8%, Stroke Riskometer™ = 71·5% (95% CI 69·0%–73·9%)], and better than QStroke [males – 59·7% (95% CI 57·3%–62·0%) and comparable to females = 71·1% (95% CI 69·0%–73·1%)]. Discriminative ability of all algorithms was low (C-statistic ranging from 0·51–0·56, D-statistic ranging from 0·01–0·12). Hosmer-Lemeshow illustrated that all of the predicted risk scores were not well calibrated with the observed event data ( P < 0·006).

          Conclusions

          The Stroke Riskometer™ is comparable in performance for stroke prediction with FSRS and QStroke. All three algorithms performed equally poorly in predicting stroke events. The Stroke Riskometer™ will be continually developed and validated to address the need to improve the current stroke risk scoring systems to more accurately predict stroke, particularly by identifying robust ethnic/race ethnicity group and country specific risk factors.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

          In 2010, overweight and obesity were estimated to cause 3·4 million deaths, 3·9% of years of life lost, and 3·8% of disability-adjusted life-years (DALYs) worldwide. The rise in obesity has led to widespread calls for regular monitoring of changes in overweight and obesity prevalence in all populations. Comparable, up-to-date information about levels and trends is essential to quantify population health effects and to prompt decision makers to prioritise action. We estimate the global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013. We systematically identified surveys, reports, and published studies (n=1769) that included data for height and weight, both through physical measurements and self-reports. We used mixed effects linear regression to correct for bias in self-reports. We obtained data for prevalence of obesity and overweight by age, sex, country, and year (n=19,244) with a spatiotemporal Gaussian process regression model to estimate prevalence with 95% uncertainty intervals (UIs). Worldwide, the proportion of adults with a body-mass index (BMI) of 25 kg/m(2) or greater increased between 1980 and 2013 from 28·8% (95% UI 28·4-29·3) to 36·9% (36·3-37·4) in men, and from 29·8% (29·3-30·2) to 38·0% (37·5-38·5) in women. Prevalence has increased substantially in children and adolescents in developed countries; 23·8% (22·9-24·7) of boys and 22·6% (21·7-23·6) of girls were overweight or obese in 2013. The prevalence of overweight and obesity has also increased in children and adolescents in developing countries, from 8·1% (7·7-8·6) to 12·9% (12·3-13·5) in 2013 for boys and from 8·4% (8·1-8·8) to 13·4% (13·0-13·9) in girls. In adults, estimated prevalence of obesity exceeded 50% in men in Tonga and in women in Kuwait, Kiribati, Federated States of Micronesia, Libya, Qatar, Tonga, and Samoa. Since 2006, the increase in adult obesity in developed countries has slowed down. Because of the established health risks and substantial increases in prevalence, obesity has become a major global health challenge. Not only is obesity increasing, but no national success stories have been reported in the past 33 years. Urgent global action and leadership is needed to help countries to more effectively intervene. Bill & Melinda Gates Foundation. Copyright © 2014 Elsevier Ltd. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.

            The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches to the implementation of guidelines and their use in high-risk populations.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

                Bookmark

                Author and article information

                Journal
                Int J Stroke
                Int J Stroke
                ijs
                International Journal of Stroke
                BlackWell Publishing Ltd (Oxford, UK )
                1747-4930
                1747-4949
                February 2015
                10 December 2014
                : 10
                : 2
                : 231-244
                Affiliations
                [1 ]AUT University NZ
                [2 ]Erasmus University, Medical Center Rotterdam, The Netherlands
                [3 ]Research Center of Neurology, RAMS Russia
                [4 ]Department of Medicine, School of Clinical Sciences, Monash University Australia
                [5 ]Lund University Sweden
                [6 ]Beijing Neurosurgical Institute China
                [7 ]Stroke Foundation of Bengal India
                [8 ]University of Auckland NZ
                [9 ]Universiti Kebangsaan Malaysia Medical Center KL, Malaysia
                [10 ]University of Melbourne Australia
                [11 ]University of Toronto Canada
                [12 ]Karolinska Institutet Sweden
                [13 ]Tel-Aviv University Israel
                [14 ]Centre Hospitalo-Universitaire Dijon, France
                [15 ]University of Burgundy France
                [16 ]Danube University Austria
                [17 ]Otago University NZ
                [18 ]Emory University Atlanta, USA
                [19 ]Hospital de Santo António Portugal
                [20 ]University Hospital of Coimbra Portugal
                [21 ]National Cerebral and Cardiovascular Center Japan
                [22 ]Mayo Clinic USA
                [23 ]NIH/NHLBI USA
                [24 ]University of Sydney Australia
                [25 ]Christian Medical College Punjab, India
                [26 ]School of Medicine and Pharmacology, The University of Western Australia Australia
                [27 ]Department of Neurology, Janakpuri Super Speciality Hospital New Delhi, India
                Author notes
                Correspondence: Priya G. Parmar*, National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Studies, AUT University, AUT North Shore Campus, AA254, 90 Akoranga Dr, Northcote 0627, Private Bag 92006, Auckland 1142, New Zealand., E-mail: pparmar@ 123456aut.ac.nz

                Conflict of interest: Coauthors from the AUT University (P. P., R. K., M.A., E.R., T. H., P. H., R. B., M. P., V. L. F.) declare that funds resulting from the sale of the professional version of the Stroke Riskometer™ app go in to further research and education for stroke prevention. None of the other authors has competing financial interests.

                Funding: Faculty of Health and Environmental Studies, AUT University, Private Bag 92006, Auckland, NZ.

                [†]

                Stroke Riskometer™ Collaboration Writing Group

                Article
                10.1111/ijs.12411
                4335600
                25491651
                2a7741eb-b06e-4e03-88cf-0164d2e02d1b
                © 2014 The Authors. International Journal of Stroke published by John Wiley & Sons Ltd on behalf of World Stroke Organization.

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 08 September 2014
                : 28 October 2014
                Categories
                Research

                Cardiovascular Medicine
                prevention,stroke prediction,stroke riskometer™ app,validation
                Cardiovascular Medicine
                prevention, stroke prediction, stroke riskometer™ app, validation

                Comments

                Comment on this article